C. Huang et al. / Bioorg. Med. Chem. Lett. 20 (2010) 4665–4669
4669
White, E. H.; Roswell, D. F.; Dupont, A. C.; Wilson, A. A. J. Am. Chem. Soc. 1987,
109, 5189; (i) Rothman, J. H.; Still, W. C. Bioorg. Med. Chem. Lett. 1999, 9, 509.
6. Watterson, S. H.; Chen, P.; Zhao, Y.-F.; Gu, H. H.; Murali Dhar, T. G.; Xiao, Z.-L.;
Ballentine, S. K.; Shen, Z.-Q.; Fleener, C. A.; Rouleau, K. A.; Obermeier, M.; Yang,
Z.; Mcintyre, K. M.; Shuster, D. J.; Witmer, M.; Dambach, D.; Chao, S.; Mathur,
A.; Chen, B.-C.; Barrish, J. C.; Robl, J. A.; Townsend, R.; Iwanowicz, E. J. J. Med.
Chem. 2007, 50, 3730.
7. (a) Tabarrini, O.; Manfroni, G.; Fravolini, A.; Cecchetti, V.; Sabatini, S.; Clerca, E.
D.; Rozenski, J.; Canard, B.; Dutartre, H.; Paeshuyse, J.; Neyts, J. J. Med. Chem.
2006, 49, 2621; (b) Akanitapichat, P.; Bastow, K. F. Antiviral Res. 2002, 53, 113;
(c) Stankiewicz-Drogon, A.; Palchykovska, L. G.; Kostina, V. G.; Alexeeva, I. V.;
Shved, A. D.; Boguszewska-Chachulska, A. M. Bioorg. Med. Chem. 2008, 16,
8846; (d) Yamamoto, N.; Furukawa, H.; Ito, Y.; Yoshida, S.; Maeno, K.;
Nishiyama, Y. Antiviral Res. 1989, 12, 21; (e) Manfroni, G.; Paeshuyse, J.;
Massari, S.; Zanoli, S.; Gatto, B.; Maga, G.; Tabarrini, O.; Cecchetti, V.; Fravolini,
A.; Neyts, J. J. Med. Chem. 2009, 52, 3354.
8. Singh, P.; Kaur, J.; Yadav, B.; Komath, S. S. Bioorg. Med. Chem. 2009, 17, 3973.
9. (a) Radzikomki, C.; Wysocka-Skrzela, B.; Jrabomka, M.; Konopa, J.; Kereczek-
Marawska, E.; Onmzko, K.; Ledochowaki, Z. Arch. Immunol. Ther. Exp. 1971, 19,
219; (b) Pelkowska, A.; Kowdczyk-Bronisz, S. H.; Blaszcyzk, B.; Gieldanowski, J.;
Patkowski, J. Arch. Immunol. Ther. Exp. 1973, 22, 823; (c) Antonini, I.; Polucci, P.;
Magnano, A.; Gatto, B.; Palumbo, M.; Menta, E.; Pescalli, N.; Martelli, S. J. Med.
Chem. 2003, 46, 3109; (d) Boumendjel, A.; Macalou, S.; Ahmed-Belkacem, A.;
Blanca, M.; Pietrob, A. D. Bioorg. Med. Chem. 2007, 15, 2892; (e) Dodic, N.;
Dumaitre, B.; Daugan, M.; Pianetti, P. J. Med. Chem. 1995, 38, 2418; (f) Chao, H.-
J.; Jun, M.-J.; Kwonb, Y.; Na, Y. Bioorg. Med. Chem. Lett. 2009, 19, 6766; (g)
Boutefnouchet, S.; Gaboriaud-Kolar, N.; Minh, N. T.; Depauw, S.; David-
Cordonnier, M. H.; Pfeiffer, B.; Léonce, S.; Pierré, A.; Tillequin, F.; Lallemand,
M. C.; Michel, S. J. Med. Chem. 2008, 51, 7287.
with water to give a crude product, which was further recrystallized by ethyl
acetate to form the final products 2.
13. General procedure for the synthesis of polyhalo acridone 3: Polyhalo
isophthalonitrile 2 (2 mmol) was suspended in 6 mL of 95–98% sulfuric acid.
The reaction mixture was stirred at 90 °C for 1 h. After the reaction, the
mixture was cooled to room temperature, put into a beaker (100 mL) with
50 mL iced water, and then neutralized with solid Na2CO3 to a pH of 9–10. The
solid was filtered off and washed with water to give a crude product that was
purified by flash column chromatography, to afford polyhalo acridone 3 in 76–
86% yield. 1,3,4-Trichloro-9-oxo-9,10-dihydroacridine-2-carbox-amide 3a:
yellow solid, mp: 251–252 °C. IR (KBr): 3478, 3416, 1665, 1568, 1398, 1326,
1164, 755, 612 cmÀ1 1H NMR (500 MHz, DMSO-d6): d 8.48–8.18 (m, 3H, PhH),
.
7.95–7.80 (m, 3H, NH2, PhH), 7.48 (br, 1H, NH). 13C NMR (125 MHz, DMSO-d6):
d 162.7, 152.5, 148.5, 145.5, 132.2, 131.9, 130.7, 130.0, 129.2, 125.4, 124.4,
123.4, 115.0, 108.4. HRMS (TOF ES+): m/z calcd for C14H8Cl3N2O2 [(M+H)+],
340.9646; found, 340.9644. 4-Chloro-1,3-difluoro-9-oxo-9,10-dihydroacrid- ine-
2-carboxamide 3b: yellow solid, mp: >300 °C. IR (KBr): 3486, 3371, 3246, 1679,
1559, 1382, 1260, 834, 759, 601 cmÀ1 1H NMR (500 MHz, DMSO-d6): d 8.54–
.
7.78 (m, 6H, PhH, NH2), 7.46–7.43 (br, 1H, NH). 13C NMR (125 MHz, DMSO-d6):
d 161.3, 156.2 (d, J = 267.5 Hz), 154.8 (d, J = 258.8 Hz), 151.8, 149.5, 145.2,
132.5, 129.1, 123.8, 123.4, 114.1, 111.6, 109.1 (t, J = 27.5 Hz), 101.2 (d,
J = 32.5 Hz). 19F NMR (470 MHz, DMSO-d6):
d
À111.3 (d, J = 4.7 Hz, 1F),
À111.7 (d, J = 4.7 Hz, 1F). HRMS (TOF ES+): m/z calcd for C14H8ClF2N2O2
[(M+H)+],
309.0237;
found,
309.0233.
1,3,4-Trifluoro-9-oxo-9,10-
dihydroacridine-2-carboxamide 3c: yellow solid, mp: >300 °C. IR (KBr): 3526,
3421, 3151, 1685, 1557, 1388, 1265, 967, 758, 602 cmÀ1 1H NMR (500 MHz,
DMSO-d6):
8.53–7.78 (m, 6H, PhH, NH2), 7.44 (br, 1H, NH). 13C NMR
.
d
(125 MHz, DMSO-d6): d 161.0, 152.6 (d, J = 261.3 Hz), 151.2, 149.4, 145.3 (d,
J = 252.5 Hz), 140.5 (d, J = 248.8 Hz), 140.4, 132.4, 129.1, 123.7, 123.5, 114.1,
108.4 (t, J = 25.0 Hz), 101.2. HRMS (TOF ES+): m/z calcd for C14H8F3N2O2
[(M+H)+], 293.0532; found, 293.0529. 4,7-Dichloro-1,3- difluoro-9-oxo-9,10-
dihydro-acridine-2-carboxamide 3d: yellow solid, mp: >300 °C. IR (KBr): 3433,
10. (a) Bahr, N.; Tiemey, E.; Reymond, J. L. Tetrahedron Lett. 1997, 38, 1489; (b)
White, E.; Roswell, D. F.; Dupont, A. C.; Wilson, A. A. J. Med. Chem. 1987, 109,
5189; (c) Lunardi, C. N.; Bonilha, J. B. S.; Tedesco, A. C. J. Lumin. 2002, 99, 61; (d)
Qiu, B.; Guo, L.-H.; Chen, Z.-T.; Chi, Y.-W.; Zhang, L.; Chen, G.-N. Biosens.
Bioelectron. 2009, 24, 1281.
3353, 3245, 1650, 1554, 1376, 1251, 1102, 834, 630 cmÀ1 1H NMR (500 MHz,
.
DMSO-d6):
d
8.67 (br, 1H, NH), 8.28–7.74 (m, 6H, PhH, NH2). 13C NMR
11. (a) Yan, S.-J.; Huang, C.; Su, C.-X.; Ni, Y.-F.; Lin, J. J. Comb. Chem. 2010, 12, 91; (b)
Yan, S.-J.; Huang, C.; Zheng, X.-H.; Huang, R.; Lin, J. Bioorg. Med. Chem. Lett.
2010, 20, 48; (c) Shu, L.-J.; Mayor, M. Chem. Commun. 2006, 4134; (d) Kitazume,
T.; Nakajima, S. J. Fluorine Chem. 2004, 125, 1447; (e) Chan, P. K.; Leong, W. K.
Organometallics 2008, 27, 1247.
12. General procedure for the synthesis of polyhalo isophthalonitrile 2: A 50 mL
round-bottomed flask was charged with polyhalo isophthalonitrile 1 (5 mmol),
DMF (30 mL), aniline derivatives (6.0 mmol), and potassium carbonate 1.4 g
(10 mmol). The solution was stirred for 0.5–18 h at room temperature until the
substrate 1 was completely consumed. The mixture was put into a beaker
(100 mL) and quenched by the addition of water (30 mL). The reaction mixture
was stirred for another 15 min, and then filtered off. The residue was washed
(125 MHz, DMSO-d6): d 161.0, 156.0 (d, J = 255.0 Hz), 155.0 (d, J = 247.5 Hz),
151.2, 147.9, 145.4, 132.9, 131.3, 128.2, 122.4, 114.6, 111.8, 109.9 (t,
J = 26.3 Hz), 101.2. HRMS (TOF ES+): m/z calcd for C14H7Cl2F2N2O2 [(M+H)+],
342.9847; found, 342.9845. 7-Chloro-1,3,4-trifluoro-9,10-dihydro-9-oxoacri-
dine-2-carboxamide 3e: yellow solid, mp: 181–185 °C. 19F NMR (467 MHz,
DMSO-d6): d À115.4 (d, J = 14.1 Hz, 1F), À139.3 (s, 1F), À155.9 (d, J = 14.1 Hz,
1F). HRMS (TOF ES+): m/z calcd for C14H7ClF3N2O2 [(M+H)+], 327.0143; found,
327.0140.
14. (a) Eaton, D. J. Photochem. Photobiol., B 1988, 2, 523; (b) Ci, Y.-X.; Jia, X. Chin. J.
Anal. Chem. 1986, 14, 616.
15. Mossman, T. J. Immunol. Methods 1983, 65, 55.